Publicacions
-
Pastor-Anglada M and Perez-Torras S.
Emerging Roles of Nucleoside Transporters.
FRONTIERS IN PHARMACOLOGY . 9: 606-606. Nº de cites: 107
-
Urtasun N, Boces-Pascual C, Boix L, Bruix J, Pastor-Anglada M and Perez-Torras S.
Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.
Oncotarget . 8(52): 90185-90196. Nº de cites: 7
-
Grañé-Boladeras N, Perez-Torras S, Lozano JJ, Romero MR, Mazo A, Marín JJ and Pastor-Anglada M.
Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.
PHARMACOLOGICAL RESEARCH . 113(Pt A): 364-375. Nº de cites: 4
-
Perez-Torras S, Iglesias I, Llopis M, Lozano JJ, Antolín M, Guarner F and Pastor-Anglada M.
Transportome Profiling Identifies Profound Alterations in Crohn's Disease Partially Restored by Commensal Bacteria
JOURNAL OF CROHNS & COLITIS . 10(7): 850-859. Nº de cites: 17
-
Urtasun N, Vidal-Pla A, Perez-Torras S and Mazo A.
Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors
BMC Cancer . 15: 223-223. Nº de cites: 17
-
Minami K, Shinsato Y, Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara K, Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Perez-Torras S, Pastor-Anglada M, Furukawa T and Yasuo T.
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
JOURNAL OF PHARMACOLOGICAL SCIENCES . 127(3): 319-325. Nº de cites: 43
-
Pastor-Anglada M and Perez-Torras S.
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.
FRONTIERS IN PHARMACOLOGY . 6: 13-13. Nº de cites: 85
-
Perez-Torras S, Vidal-Pla A, Cano-Soldado P, Huber-Ruano I, Mazo A and Pastor-Anglada M.
Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.
CELL DEATH & DISEASE . 4: . Nº de cites: 24
-
Trigueros-Motos L, Perez-Torras S, Casado FJ, Molina-Arcas M and Pastor-Anglada M.
Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.
BMC Cancer . 12: 434-434. Nº de cites: 31
-
Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Perez-Torras S, Kipp H, Koepsell H and Pastor-Anglada M.
Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.
MOLECULAR PHARMACOLOGY . 82(1): 59-67. Nº de cites: 12